Pharm - HTN Flashcards
BP goal for people ≥ 60 yo
<150/90
Bp goal for people <60 yo
<140/90
goal for people with CKD OR DM
<140/90
4 drug classes to choose from non-aa with HTN
- Thiazide-type diuretic
- Calcium channel blocker
- Angiotensin-converting enzyme inhibitor (ACEI)
- Angiotensin receptor blocker (ARB)
2 drug classes to choose from for aa with HTN
- Thiazide-type diuretic
* Calcium channel blocker
What is next step if BP goal not met within 1 month
- increase dose of 1st drug
- add 2nd drug
what is next step if BP goal is not met with two drugs
- add a 3rd
what is next step if BP can’t be met with 3 drugs from initial 4 drug class list OR if can’t use those drugs due to contraindications
turn to other classes
what two drugs from the top 4 list should not be used together
ARB and ACEI
What are the 5 lifestyle change recommendations (list)
- Lose weight if overweight (BMI goal 18.5-24.9)
- DASH diet
- Reduce dietary sodium (<2.4 g Na/day)
- Increase physical activity
- moderation of alcohol consumption (Men ≤ 2 drinks, women ≤ 1 drinks)
Overview of DASH diet
- fruits and vegetables
- low fat dairy
- high potassium and calcium
Generic name for thiazide type diurietic
hydrocholorthiazide
Generic name for loop diurietic
furosemide
Generic name for potassium sparing diurietic
Triamterene
Generic name for ACEI
Lisinopril
Generic name for ARB
Losartan
Generic name for non-dihydropyridine calcium channel blocker (2)
Verapamil
Diltiazem
Generic name for dihydropyridine calcium channel blocker
Amlodipine
Generic name for aldosterone receptor blocker
Aldactone
Generic name for adrenergic inhibitor - peripheral
Reserpine
Generic name for adrenergic inhibitor - central alpha agonist
clonidine
Generic name for beta-blocker, cardio selective
Atenolol
metoprolol from Dr. Letassy’s lecture
Generic name for beta-blocker, non-specific
propranolol
Generic name for alpha-1 blocker
Doxazosin
Generic name for combined alpha & beta blocker
Carvedilol
Generic name for direct vasodilator
Minoxidil
MoA
Thiazide-type diuretic
- Acutely reduce blood pressure due to diuresis
- chronically probably mobilize sodium and water from arteriolar walls reducing vascular tone OR they directly relax vascular smooth muscles
MoA
Loop diuretic
Diuresis, maybe vascular smooth muscle relaxation
MoA Potassium-sparing diuretic
Weakly antihypertensive; used for potassium sparing usually in combination with a thiazide diuretic
MoA ACEI
- Blocks angiotensin converting enzyme
– reduced levels of angiotensin II, a potent vasoconstrictor - reduced levels of aldosterone (hormone that promotes water/Na retention by the kidney)
- Net effect is reduced tone of arterioles = lower BP
MoA ARB
- Directly blocks actions of angiotensin II, potent vasoconstrictor and stimulator of the release of aldosterone.
- Result is reduced arteriolar tone and lower BP
MoA calcium channel blocker non-dihydropyridine
- Inhibits influx of Ca into smooth muscle cells of peripheral vasculature = relaxation and reduced vascular tone
- Also reduced chronotropy and inotropy
MoA calcium channel blocker dihydropyridine
- Inhibits influx of Ca into smooth muscle cells of peripheral vasculature = relaxation and reduced vascular tone. More potent than non-dihydropyridines
- Does not reduce chronotropy or inotropy to same degree as non-dihydropyridines
MoA aldosterone receptor blocker
Binds to aldosterone receptors in renal tubules, blocks aldosterone binding
- increased water and sodium excretion = relaxation of blood vessels
MoA peripheral adrenergic inhibitors
- Depletes norepinephrine from sympathetic nerve endings in peripheral nervous system
- Blocks transport of norepinephrine into storage granules
- Results in reduced arteriolar tone and lower BP
MoA Central alpha-agonist adrenergic inhibitors
- Stimulates alpha-2 receptors in brainstem leading to decreased sympathetic outflow from vasomotor center
- Results in reduced arteriolar tone and lower BP
MoA alpha-1 blockers
- blocks alpha-1 receptors on arterioles
* relaxation of arterioles and reduced vascular tone
MoA beta-blockers
• Not fully known
• Related to:
1. decreased sympathetic outflow from CNS
2. reduced cardiac output
3. reduced renin release by juxtoglomerular cells in the kidney
MoA combo alpha/beta blockers
effects of each together in one little pill
MoA direct vasodilators
directly relaxes arteriolar smooth muscle
thiazide-type diuretics ADR
- Short-term increase in cholesterol and glucose levels
- Decreased serum levels of potassium, sodium, chloride, and magnesium
- Increased serum levels of uric acid and calcium
thiazide-type diuretics monitoring parameters
- Chem-7
- BP
- some pts: uric acid, ca, mg
Loop diuretics ADR
- Short-term increase in cholesterol and glucose levels
- Decreased serum levels of potassium, sodium, chloride, magnesium AND CALCIUM (unlike thiazide type which doesn’t affect Ca)
- Increased serum levels of uric acid and calcium
Loop diuretic monitoring parameters
Chem-7
BP
Potassium sparing diuretic ADR
Hyperkalemia
Potassium sparing diuretic monitoring parameters
Chem-7
BP
ACEI ADR
- Cough (lisinopril)
- Hyperkalemia (esp. DM and renal insufficiency)
- Angioedema
- Rash
- Loss of taste
- Contraindicated in pregnancy
ACEI monitoring parameters
- chem-7
- bp
- question for ADR
- PE
ARB ADR
- Hyperkalemia (esp. DM and renal insufficiency)
* Contraindicated in pregnancy
ARB monitoring
- chem-7
- BP
Non-dihydropyridine calcium channel blockers ADR
- Slowed cardiac conduction
- Worsening of systolic fn in heart failure (negative inotropic effect)
- Constipation
Non-dihydropyridine calcium channel blockers monitoring parameters
- BP
- EKG
- question for ADR
dihydropyridine calcium channel blockers ADR
- Ankle edema
- Flushing
- HA
dihydropyridine calcium channel blockers monitoring parameters
- BP
- question for ADR
- PE
Aldosterone receptor blockers ADR
- hyperkalemia
- gynecomastia (warn patients first!!)
Aldosterone receptor blockers monitoring parameters
- chem-7
- BP
Peripheral adrenergic inhibitors ADR
- nasal congestion
- sedation
Peripheral adrenergic inhibitors monitoring
- bp
- question for ADR
Central alpha-agonist adrenergic inhibitors ADR
- Sedation
- Dry mouth
- Lethargy
- Bradycardia
- Withdrawal rebound HTN
- Impaired cognitive fn in elderly
Central alpha-agonist adrenergic inhibitors monitoring parameters
- BP
- EKG
- Question for ADR
alpha-1 blocker ADR
Postural hypotension – esp after 1st dose & in elderly or people with DM (impaired autonomic nervous system function)
alpha-1 blocker monitoring
- BP
- questions for ADR
combined beta/alpha blockers monitoring
- BP
- EKG
- Question for ADR
direct vasodilators ADR
- Orthostatic hypotension (esp older pt)
- HA
- Fluid retention
- Tachycardia
- Hirsutism
direct vasodilators monitoring parameters
- BP
- question for ADR
- PE
LO: • Indicate appropriate initial therapy for a patient with hypertension when given pertinent details of their medical history
go through patient examples provided by Dr. Britton
When fu after starting BP pharmacotherapy
one month
* more frequent if significant elevation and/or complicating co-morbidities
What are the three main strategies to start pharm therapy for BP
- Start one drug, titrate to max before adding second
- Start one drug then add a second drug before maxing out first
- Begin with 2 drugs at once, either as two separate tabs or as a combo
9 meds that can be associated with HTN
- NSAIDS
- Cocaine, amphetamines, other illicit drugs
- Sympathomimetics (common in OTC cold/allergy meds)
- Oral contraceptives
- Adrenal steroids
- Cyclosporine
- Erythropoietin
- Licorice
- OTC – ephedra, ma huang, bitter orange